A prospective, randomized, controlled trial to evaluate the effect of prophylactic sandostatin on ERCP-induced hyperamylasemia and pancreatitis

Gastroenterological Journal of Taiwan

Volumn 14, Issue 2, 1997, Pages 192-197

  Ng, K W ^a   Jiang, C F ^a   Liang, C T ^a   Wu, C S ^a   Chen, H C ^a   Yang, C L ^a   Tan S , W ^a   Yeh, C H ^a  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Amylase; ERCP; Lipase; Pancreatitis

Indexed keywords

AMYLASE; OCTREOTIDE; SCOPOLAMINE BUTYL BROMIDE; SOMATOSTATIN DERIVATIVE; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; HYPERAMYLASEMIA; INCIDENCE; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PANCREATITIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031428109     PISSN: 10137696     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)